| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Arthur Kuan is Chief Executive Officer at CGON. Arthur Kuan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $12.7M at current prices.
Arthur Kuan has 5 Form 4 filings on record from October 2024 to April 2026, all as Chief Executive Officer at CG Oncology (CGON), 2024–2026.
The 7 reported transactions were 3 option or other derivative awards, 2 option exercises and 2 tax withholdings.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria